714 related articles for article (PubMed ID: 18785808)
21. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
22. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
Lie AK; Kristensen G
Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
26. HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway.
Sorbye SW; Fismen S; Gutteberg TJ; Mortensen ES
J Virol Methods; 2010 Oct; 169(1):219-22. PubMed ID: 20638416
[TBL] [Abstract][Full Text] [Related]
27. Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination.
Johnson K
CMAJ; 1995 Feb; 152(4):483-93. PubMed ID: 7859196
[TBL] [Abstract][Full Text] [Related]
28. Assessing new technologies for cervical cancer screening: beyond sensitivity.
Massad LS
J Low Genit Tract Dis; 2008 Oct; 12(4):311-5. PubMed ID: 18820547
[TBL] [Abstract][Full Text] [Related]
29. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
[TBL] [Abstract][Full Text] [Related]
30. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change.
Franco EL; Mahmud SM; Tota J; Ferenczy A; Coutlée F
Arch Med Res; 2009 Aug; 40(6):478-85. PubMed ID: 19853188
[TBL] [Abstract][Full Text] [Related]
31. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination.
Franco EL; Cuzick J; Hildesheim A; de Sanjosé S
Vaccine; 2006 Aug; 24 Suppl 3():S3/171-7. PubMed ID: 16844268
[TBL] [Abstract][Full Text] [Related]
32. Natural history and epidemiology of HPV infection and cervical cancer.
Castellsagué X
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening: from the Papanicolaou smear to the vaccine era.
Crum CP; Abbott DW; Quade BJ
J Clin Oncol; 2003 May; 21(10 Suppl):224s-230s. PubMed ID: 12743139
[TBL] [Abstract][Full Text] [Related]
34. HPV testing and vaccination in Europe.
Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic tests for HPV infection.
Chin-Hong PV; Klausner JD
MLO Med Lab Obs; 2004 Oct; 36(10):10-2, 14-6; quiz 18-9. PubMed ID: 15536803
[TBL] [Abstract][Full Text] [Related]
36. [Use of molecular tests of human papilloma virus (HPV) as screening test for cervix cancer: a review].
Ronco G
Epidemiol Prev; 1999; 23(4):372-7. PubMed ID: 10730479
[TBL] [Abstract][Full Text] [Related]
37. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
39. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.
Franco EL; Harper DM
Vaccine; 2005 Mar; 23(17-18):2388-94. PubMed ID: 15755633
[TBL] [Abstract][Full Text] [Related]
40. Human papillomaviruses. Applications, caveats and prevention.
Crum CP; Berkowitz RS
J Reprod Med; 2002 Jul; 47(7):519-28; discussion 528-9. PubMed ID: 12170526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
